NovaBay Pharmaceuticals’ Avenova® Warm Eye Compress for the Relief of Symptoms Associated with Dry Eye is Now Available on...
March 31 2021 - 6:50AM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a
pharmaceutical company focusing on commercializing Avenova for the
eye care market, announces the availability of its new Warm Eye
Compress on Amazon.com and on Avenova.com. This new, reusable
heated eye compress is designed to relieve the symptoms associated
with blepharitis, dry eye disease, meibomian gland disease, styes
and chalazion, and is a companion product to Avenova, NovaBay’s
premier antimicrobial lid and lash spray.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210331005290/en/
Avenova Warm Eye Compress (Graphic:
Business Wire)
“Most people who suffer from dry eye are unable to produce
adequate lubrication for their eyes, either due to insufficient
tear production or poor-quality tears,” said Justin Hall, President
and CEO of NovaBay Pharmaceuticals. “Avenova Warm Eye Compress
helps to hydrate and lubricate eyes to efficiently expel bacteria
and debris, making eyes feel refreshed and rejuvenated. When used
together with our Avenova lid and lash spray – which is clinically
proven to treat the underlying cause of bacterial dry eye, rather
than just the symptoms – the eyes will start to restore the natural
defenses against tear evaporation.”
The Avenova Warm Eye Compress stimulates the meibomian glands to
produce more tears, thereby clearing these glands and allowing
natural oils to flow back onto the eye, as well as preventing tears
from evaporating too quickly. The compress also improves blood
circulation and helps to relax the eye, which may increase
comfort.
To enjoy the many benefits of the Avenova Warm Eye Compress,
simply heat it in a microwave oven for 15-20 seconds and place it
over closed eyelids for up to 15-20 minutes or as directed by a
physician. Then gently wipe the skin surrounding your eyes with a
wet cloth. The compress should be left to air dry or can be hand
washed, and will usually be ready for reuse within two hours.
Currently in stock on both the Amazon and the Avenova websites, the
Avenova Warm Eye Compress is available for $17.50 and shipping is
free on Avenova.com.
About NovaBay Pharmaceuticals, Inc.: Going Beyond
Antibiotics®
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company
focusing on high-quality, differentiated, anti-infective consumer
products: Avenova®, the premier antimicrobial lid and lash spray,
CelleRx® Clinical Reset™, a breakthrough product in the beauty
category, and NeutroPhase® Skin and Wound Cleanser for wound
healing. NovaBay’s products are formulated with its patented, pure,
stable, pharmaceutical-grade hypochlorous acid that replicates the
antimicrobial chemicals used by white blood cells to fight
infection. NovaBay’s hypochlorous acid products do not cause
stinging or irritation, are non-toxic and non-sensitizing, making
them completely safe for regular use. Avenova is the only
commercial hypochlorous acid lid and lash spray product clinically
proven to reduce bacterial load on ocular skin surfaces, thus
effectively addressing the underlying cause of bacterial dry
eye.
Forward-Looking Statements
Except for historical information herein, matters set forth in
this press release are forward-looking within the meaning of the
“safe harbor” provisions of the Private Securities Litigation
Reform Act of 1995, including statements about the commercial
progress and future financial performance of NovaBay
Pharmaceuticals, Inc. This release contains forward-looking
statements that are based upon management’s current expectations,
assumptions, estimates, projections and beliefs. These statements
include, but are not limited to, statements regarding our current
product offerings, potential future product offerings, and any
future revenue that may result from selling these products, as well
as generally the Company’s expected future financial results. These
statements involve known and unknown risks, uncertainties and other
factors that may cause actual results or achievements to be
materially different and adverse from those expressed in or implied
by the forward-looking statements. Factors that might cause or
contribute to such differences include, but are not limited to,
risks and uncertainties relating to the size of the potential
market for our products, the possibility that the available market
for the Company’s products will not be as large as expected, the
Company’s products will not be able to penetrate one or more
targeted markets, revenues will not be sufficient to meet the
Company’s cash needs, the effect on sales and potential
reputational damage resulting from decisions or actions taken by
regulators, including Warning Letters issued by the FDA, and any
other potential regulatory problems that may arise. Other risks
relating to NovaBay’s business, including risks that could cause
results to differ materially from those projected in the
forward-looking statements in this press release, are detailed in
NovaBay’s latest Form 10-Q/K filings with the Securities and
Exchange Commission, especially under the heading “Risk Factors.”
The forward-looking statements in this release speak only as of
this date, and NovaBay disclaims any intent or obligation to revise
or update publicly any forward-looking statement except as required
by law.
Socialize and Stay informed on
NovaBay’s progress Like us on Facebook Follow us on
Twitter Connect with NovaBay on LinkedIn Visit NovaBay’s
Website
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com.
Avenova.com
CelleRx Clinical Reset Purchasing
Information For NovaBay CelleRx Clinical Reset
purchasing information Please call 877-CELLERX www.CelleRx.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210331005290/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor Contact LHA
Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Apr 2023 to Apr 2024